Frankfurt am Main (pta041/11.08.2021/21:55 UTC+2)
capsensixx AG with strong 1st mid-year 2021 and significant increase in earnings
Frankfurt am Main, 11/08/2021
capsensixx closed the first mid-year of 2021 with a very strong 1st mid-year and a significant improvement in earnings. The excellent business development in the 1st mid-year provides an indication of the capsensixx Group's medium-term growth potential.
The following key figures for the years 2020 and 2021 are given before deduction of third party shares, unless otherwise indicated.
In the first six months of 2021, EBITDA increased by 14 % to EUR 4.5 million compared to the same period in 2020 (EUR 3.9 million).
Consolidated earnings before taxes for the first six months of the financial year 2021 were EUR 4.1 million. Compared to the same period of the previous year (EUR 2.8 million), this represents an increase of EUR 1.3 million (+47.3 %).
Earnings after taxes (without non-controlling interests) increased to EUR 1.3 million (+51.2 %) in the first six months of the financial year 2021 (previous year: EUR 0.9 million).
The first six months of the 2021 financial year of the capsensixx Group exceeded the plan data and show a very positive and sustainable profitable operational development. If the market environment remains unchanged, the Management Board expects an ongoing increase in earnings concerning the further course of the financial year 2021. In the medium term, it is also expected that the high level of investment will further increase the growth trend.
The Interim Semi Annual Report 2021 of capsensixx AG will be available from August 30, 2021 at https://www.capsensixx.de/berichte/
60325 Frankfurt am Main
|Contact Person:||Martin Stuerner|
|Phone:||+49 69 7680585-25|
|Stock Exchange(s):||Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate|